Top

Reactions Weekly

Published in:

01-03-2023 | COVID-19 | Case report

Methylprednisolone/mycophenolate-sodium/tacrolimus

Acute T cell-mediated rejection, COVID-19 and Off label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Soleimani N, et al. A renal transplant patient with COVID-19 presented with acute cellular rejection. Journal of Nephropathology 12: 1-3, No. 1, Jan 2023. Available from: URL: https://www.nephropathol.com

Title: Methylprednisolone/mycophenolate-sodium/tacrolimus
Acute T cell-mediated rejection, COVID-19 and Off label use: case report
Publication date: 01-03-2023
Publisher: Springer International Publishing
Keywords: COVID-19
Tacrolimus
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-36263-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Methylprednisolone/mycophenolate-sodium/tacrolimus

Acute T cell-mediated rejection, COVID-19 and Off label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drug

Doxorubicin

AZD 1222

Antituberculars

Rituximab biosimilar: no increased risk of hypersensitivity reactions

Sumatriptan/tizanidine